SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) July 16, 2001
BICO, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
2275 Swallow Hill Road, Bldg. 2500, Pittsburgh, Pennsylvania 15220
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 429-0673
_________________________________________________________
(Former name or former address,if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
BICO, Inc. subsidiary, ViaCirq, Inc., developer
and marketer of the ThermoChem HT System for
delivering intraperitoneal hyperthermia (IPH),
announced today it has recruited an initial five
top product specialists with another group of
product specialists planned for recruitment by
September 2001.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial
Information and Exhibits.
(a) Financial Statements and Businesses Acquired
- Not Applicable.
(b) Pro Forma Financial Information
- Not Applicable.
(c) Exhibits - Press Release.
SIGNATURES
Pursuant to the requirement of the Securities Exchange
Act of 1934, the Registrant has duly caused this Report to
be signed on its behalf by the undersigned hereunto duly
authorized.
BICO, INC.
by /s/Fred E. Cooper
Fred E. Cooper, CEO
DATED: July 16, 2001
BICO SUBSIDIARY, VIACIRQ, ANNOUNCES RECRUITMENT OF FIVE TOP
INDUSTRY PRODUCT SPECIALISTS
Pittsburgh, PA - July 16, 2001 - BICO, Inc. (OTCBB:BIKO)
subsidiary, ViaCirq, Inc., developer and marketer of the
ThermoChem HT System for delivering intraperitoneal
hyperthermia (IPH), announced it has recruited an initial
five top product specialists with another group of product
specialists planned for recruitment by September 2001.
Tiffanie Heller, formerly an account representative
with US Surgical Corporation, a division of Tyco
Healthcare, was the recipient of the Tyco Chairman's
Council Award both in 1999 and 2000; Rob Fulkus, formerly
an account representative with US Surgical Corporation, was
also a Tyco Chairman's Council Award recipient; Christopher
Wyatt, was district manager of the U.S. Mid-Atlantic region
for Bard Access Systems and inducted into the President's
Gold Club in January 1998; Dan Daniels was territory sales
manager for Novametrix Medical Systems and was a top non-
invasive cardiac output monitor salesman in the U.S.; Joe
Palianto, was senior territory manager for ThermoCardio
Systems/Thoratec, where he was regional sales manager of
the year in 1996 and 1997. These recruited product
specialists are highly experienced medical device sales
professionals who have demonstrated high levels of success
in the introduction and adoption of surgical technologies,
having made major contributions to their respective
companies.
In addition, these individuals bring significant
relationships with key surgeon practitioners and operating
room management personnel who will facilitate the adoption
of the ThermoChem HT System.
This major step is in conjunction with the appointment
in March 2001 of the Executive Management team of Bob Egan,
formerly Executive Vice President for the U.S. Business
units of Sherwood-Davis & Geck, a division of American Home
Products; Peter DiGasbarro, formerly Senior Vice President
of Marketing for Sherwood-Davis & Geck, and Jim Hall,
formerly Divisional Business Director of US Surgical
Corporation and the build-out of the organization and
quality system to support the official launch of the
ThermoChem HT System at the Society of Gynecologic
Oncologists and Society of Surgical Oncology, two major
surgeon specialty conferences held in March 2001.
According to Jim Hall, Vice President of Sales for
ViaCirq, "The addition and training of the product
specialists allows us to serve the demand created from our
successful product launch as well as introduce this
technology to surgeons nationwide. The product specialist
team is committed to providing the highest levels of
service, training and on-going education to allow
healthcare providers to offer intraperitoneal hyperthermia
(IPH) as an adjunctive therapy with surgery and
chemotherapy to their patients who have few, if any,
options remaining for treating their advanced peritoneal
carcinomatosis. The initial response from the surgical
community has been very positive and we are anxious to move
forward in the execution of our sales and marketing plan.
These product specialists will greatly enhance the
execution of the Company's commercial strategy in pursuing
a platform approach to maximize the opportunities for the
ThermoChem HT technology."
BICO, Inc. has its corporate offices in Pittsburgh, PA
and is involved in the development and manufacture of
biomedical devices and environmental solutions. BICO's
subsidiary, ViaCirq, Inc., also located in Pittsburgh, PA,
is committed to developing, manufacturing and marketing
leading-edge hyperthermia products and services of the
highest quality and value.
FOR FURTHER INFORMATION, CONTACT:
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.429.0673 phone
1.412.279.9690 fax 1.412.279.5041 fax
INVESTOR RELATIONS NEWSLINE NUMBER: 1.800.357.6204
WEBSITE: www.bico.com
This press release contains statements of a forward-
looking nature. Shareholders and potential investors are
cautioned that such statements are predictions and actual
events or results may vary significantly.
# # # # #